These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 30623283)

  • 1. Optical Imaging of Triple-Negative Breast Cancer Cells in Xenograft Athymic Mice Using an ICAM-1-Targeting Small-Molecule Probe.
    Zhang Y; Wang M; Liu W; Peng X
    Mol Imaging Biol; 2019 Oct; 21(5):835-841. PubMed ID: 30623283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive Classification of Human Triple Negative Breast Cancer by PET Imaging with GRP78-Targeted Molecular Probe [
    Zhao H; Meng H; Wen J; Wang C; Liu J; Huang G
    Mol Imaging Biol; 2020 Jun; 22(3):772-779. PubMed ID: 31452065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intercellular adhesion molecule 1 antibody-mediated mesoporous drug delivery system for targeted treatment of triple-negative breast cancer.
    Wang M; Liu W; Zhang Y; Dang M; Zhang Y; Tao J; Chen K; Peng X; Teng Z
    J Colloid Interface Sci; 2019 Mar; 538():630-637. PubMed ID: 30554096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroSPECT imaging of triple negative breast cancer cell tumor xenografted in athymic mice with radioiodinated anti-ICAM-1 monoclonal antibody.
    You L; Wang X; Guo Z; Zhang D; Zhang P; Li J; Su X; Pan W; Zhang X
    Appl Radiat Isot; 2018 Sep; 139():20-25. PubMed ID: 29684714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LyP-1 Conjugated Nanoparticles for Magnetic Resonance Imaging of Triple Negative Breast Cancer.
    Abulrob A; Corluka S; Blasiak B; Gino Fallone B; Ponjevic D; Matyas J; Tomanek B
    Mol Imaging Biol; 2018 Jun; 20(3):428-435. PubMed ID: 29101636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ICAM-1 as a molecular target for triple negative breast cancer.
    Guo P; Huang J; Wang L; Jia D; Yang J; Dillon DA; Zurakowski D; Mao H; Moses MA; Auguste DT
    Proc Natl Acad Sci U S A; 2014 Oct; 111(41):14710-5. PubMed ID: 25267626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing breast cancer xenograft epidermal growth factor receptor expression by using near-infrared optical imaging.
    Wang K; Wang K; Li W; Huang T; Li R; Wang D; Shen B; Chen X
    Acta Radiol; 2009 Dec; 50(10):1095-103. PubMed ID: 19922304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo NIRF imaging-guided delivery of a novel NGR-VEGI fusion protein for targeting tumor vasculature.
    Ma W; Li G; Wang J; Yang W; Zhang Y; Conti PS; Chen K
    Amino Acids; 2014 Dec; 46(12):2721-32. PubMed ID: 25182731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radionuclide Molecular Imaging of EpCAM Expression in Triple-Negative Breast Cancer Using the Scaffold Protein DARPin Ec1.
    Vorobyeva A; Bezverkhniaia E; Konovalova E; Schulga A; Garousi J; Vorontsova O; Abouzayed A; Orlova A; Deyev S; Tolmachev V
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33066684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Cy5.5-labeled phage-displayed peptide probe for near-infrared fluorescence imaging of tumor vasculature in living mice.
    Chen K; Yap LP; Park R; Hui X; Wu K; Fan D; Chen X; Conti PS
    Amino Acids; 2012 Apr; 42(4):1329-37. PubMed ID: 21212998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cantharidin Inhibits the Growth of Triple-Negative Breast Cancer Cells by Suppressing Autophagy and Inducing Apoptosis in Vitro and in Vivo.
    Li HC; Xia ZH; Chen YF; Yang F; Feng W; Cai H; Mei Y; Jiang YM; Xu K; Feng DX
    Cell Physiol Biochem; 2017; 43(5):1829-1840. PubMed ID: 29050003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts.
    Ke S; Wen X; Gurfinkel M; Charnsangavej C; Wallace S; Sevick-Muraca EM; Li C
    Cancer Res; 2003 Nov; 63(22):7870-5. PubMed ID: 14633715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors.
    Qi S; Miao Z; Liu H; Xu Y; Feng Y; Cheng Z
    Bioconjug Chem; 2012 Jun; 23(6):1149-56. PubMed ID: 22621238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite.
    Liao WS; Ho Y; Lin YW; Naveen Raj E; Liu KK; Chen C; Zhou XZ; Lu KP; Chao JI
    Acta Biomater; 2019 Mar; 86():395-405. PubMed ID: 30660004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-Based Design of a Selective Class I Histone Deacetylase (HDAC) Near-Infrared (NIR) Probe for Epigenetic Regulation Detection in Triple-Negative Breast Cancer (TNBC).
    Zhang K; Liu Z; Yao Y; Qiu Y; Li F; Chen D; Hamilton DJ; Li Z; Jiang S
    J Med Chem; 2021 Apr; 64(7):4020-4033. PubMed ID: 33745280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An HDAC-Targeted Imaging Probe LBH589-Cy5.5 for Tumor Detection and Therapy Evaluation.
    Meng Q; Liu Z; Li F; Ma J; Wang H; Huan Y; Li Z
    Mol Pharm; 2015 Jul; 12(7):2469-76. PubMed ID: 26030093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Triple Negative Breast Cancer with a Nucleus-Directed p53 Tetramerization Domain Peptide.
    Xiao G; Annor GK; Fung K; Keinänen O; Zeglis BM; Bargonetti J
    Mol Pharm; 2021 Jan; 18(1):338-346. PubMed ID: 33289569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intercellular adhesion molecule-1-targeted near-infrared photoimmunotherapy of triple-negative breast cancer.
    Fukushima H; Kato T; Furusawa A; Okada R; Wakiyama H; Furumoto H; Okuyama S; Kondo E; Choyke PL; Kobayashi H
    Cancer Sci; 2022 Sep; 113(9):3180-3192. PubMed ID: 35723065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preparation of magnetic near infrared fluorescent probe and targeted multimodal imaging of human mesenchymal stem cells in vitro].
    Yan R; Qin J; Wang J; Liu J; Wu C; Ren L; Shan H
    Zhonghua Yi Xue Za Zhi; 2015 Jan; 95(1):56-60. PubMed ID: 25876812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ICAM-1-Targeted, Lcn2 siRNA-Encapsulating Liposomes are Potent Anti-angiogenic Agents for Triple Negative Breast Cancer.
    Guo P; Yang J; Jia D; Moses MA; Auguste DT
    Theranostics; 2016; 6(1):1-13. PubMed ID: 26722369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.